Biotech Values

[DewDiligence]

How big will FTY720 be? Here are the forecasts from some sell-side analysts:

http://www.reuters.com/article/idCNN0920214520100610

Forecasts, on average, point to sales of $987M by 2014, according to Thomson Reuters data, although some analysts expect even bigger sales. Analysts at the Jefferies brokerage expect the drug to bring in $1.6B by 2014, while Nomura forecasts $2.1B in sales by 2014.

It looks like everyone thinks FTY720 will be at least a smallish blockbuster. These analysts’ forecasts will presumably be refined when the FDA label becomes known.